Evidence map›Paper›PMID 40547151›Full record

ArticleWorld journal of gastrointestinal oncology2025

Evaluation of tumor budding, desmoplastic reaction, and lymphocytic infiltration in predicting survival for pancreatic ductal adenocarcinoma.

Anıl Alpsoy, Aysen Yavuz, Kubra Simsek, Busra Altunay, Mustafa Karaca, Betul Unal, Cumhur I Bassorgun, Ali M Tatli, Gulsum O Elpek

Abstract read
In one paragraph

Article in World journal of gastrointestinal oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Anıl AlpsoyAfyonkarahisar State Hospital, Afyonkarahisar 03000, Türkiye.
Aysen YavuzDepartment of Pathology, Akdeniz University, School of Medicine, Antalya 07070, Türkiye.
Kubra SimsekDepartment of Pathology, Akdeniz University, School of Medicine, Antalya 07070, Türkiye.
Busra AltunayKütahya City Hospital, Kütahya 43000, Türkiye.
Mustafa KaracaDepartment of Internal Medicine, Akdeniz University, Antalya 07070, Türkiye.
Betul UnalAntalya Bilim University, Antalya 07070, Türkiye.
Cumhur I BassorgunDepartment of Pathology, Akdeniz University, School of Medicine, Antalya 07070, Türkiye.
Ali M TatliDepartment of Oncology, Akdeniz University, School of Medicine, Antalya 07070, Türkiye.
Gulsum O ElpekDepartment of Pathology, Akdeniz University, School of Medicine, Antalya 07070, Türkiye. elpek@akdeniz.edu.tr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough previous findings indicated that pathological assessment of tumor budding (TB), desmoplastic reaction (DR), and tumor-infiltrating lymphocytes (TILs) may play a role in determining tumor behavior in many malignancies, the relationship between TB, DR, and TILs in patients with pancreatic ductal adenocarcinoma (PDAC) is still unknown.

aimTo evaluate relationships of TB, DR, and TILs with histopathological parameters and determine their prognostic value in patients with PDAC.

methodsThe study cohort comprised 100 patients diagnosed with PDAC. Peritumoral budding (PTB) and intratumoral budding (ITB) were assessed according to the International Tumor Budding Consensus Conference guidelines. DR was classified based on stromal maturation. TILs were evaluated semiquantitatively with a 5% cutoff. Additionally, cases were categorized into two groups according to lymphocyte density: No/Low lymphocytes and medium/high lymphocytes.

resultsA significant correlation was observed between ITB and PTB (

conclusionTB assessment stratified patients with PDAC. PTB-ITB correlation showed diagnostic relevance of ITB in biopsy specimens. The prognostic significance of DR and interplay with TIL subsets warrant further investigation.

Indexed as

Desmoplastic reactionPancreatic ductal adenocarcinomaPrognostic factorsTumor buddingTumor-infiltrating lymphocytesTumor microenvironment

Identifiers

PMID40547151
PMCPMC12179880

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.